Disclosures for "Survey Development to Assess for Barriers and Facilitators to Continuing Non-invasive Ventilation in Individuals with Amyotrophic Lateral Sclerosis"
-
Dr. Marsella has nothing to disclose.
-
Dr. Yousefi Nooraie has nothing to disclose.
-
Dr. McIntosh has nothing to disclose.
-
Ms. Gibson has received personal compensation in the range of $0-$499 for serving as a Consultant for Amylx.
-
Dr. Ciafaloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx, Alexion, Sarepta, UCB, Hoffman-LaRoche, Biogen. Dr. Ciafaloni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, AnnJi Pharmaceutical, ML-BIO, Avidity. The institution of Dr. Ciafaloni has received research support from CDC, CureSMA, FDA, Orphazyme, Sarepta, PCORI, Neurogene. Dr. Ciafaloni has received publishing royalties from a publication relating to health care.